Marc Lang

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Novartis (Switzerland)27.8%
• Al-Azhar University10.2%
• Novartis Institutes for BioMedical Research9.5%
• AstraZeneca (United Kingdom)7.7%
• Dana-Farber Cancer Institute7.4%
• Harvard University4.9%
• Other32.5%

Fields

• Medicine41.7%
• Biochemistry, Genetics and Molecular Biology31.3%
• Chemistry9.5%
• Computer Science7.1%
• Environmental Science2.8%
• Immunology and Microbiology2.8%
• Other4.7%

Topics

• HER2/EGFR in Cancer Research12.2%
• Cytokine Signaling Pathways and Interactions10.5%
• Computational Drug Discovery Methods10.1%
• Angiogenesis and VEGF in Cancer8%
• Chronic Myeloid Leukemia Treatments6.3%
• Myeloproliferative Neoplasms: Diagnosis and Treatment6.3%
• Other46.5%